Jane Street Group, LLC Ardelyx, Inc. Put Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$5.28 - $7.57 $4.11 Million - $5.89 Million	777,700 New	777,700 $5.36 Million
Q4 2021 Feb 15, 2022	BUY	$0.86 - $1.7 $149,640 - $295,800	174,000 Added 554.14%	205,400 $226,000
Q3 2021 Nov 16, 2021	SELL	$1.27 - $8.17 $17,272 - $111,112	-13,600 Reduced 30.22%	31,400 $41,000
Q2 2021 Aug 16, 2021	BUY	$6.55 - $8.98 $294,750 - $404,100	45,000 New	45,000 $341,000

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $787M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.